Table 1.

Patient characteristics

Patient Id	Age (years)	Sexa	Years since diagnosis	Baseline VLc (RNA copies/ml)	Baseline CD4 cell count (cells/mm3)	Baseline CD8 cell count (cells/mm3)	Baseline treatmentb	IL-2 administration
1	42	F	5	80	1327	1225	D4T + 3TC + NFV	NO
2	54	M	12	33	801	763	D4T + 3TC + NFV	NO
3	39	M	2	50	580	548	DDI + 3TC + NFV	NO
4	34	M	15	1200	672	819	ABV + DDI + EFV	NO
5	41	F	8	20	2702	1061	3TC + NFV + AZT	NO
6	45	F	7	20	1548	1380	DDI + D4T + NFV	YES
7	51	F	16	20	956	697	D4T + IDV + 3TC + RTV	YES
8	55	M	4	20	801	744	D4T,3TC,NFV	YES
9	61	M	5	20	1122	570	IDV + 3TC + AZT	YES
10	51	M	9	20	987	810	EFV + D4T + 3TC	YES

^aM: male; F: female.

^bD4T: Stavudine; 3TC:Lamivudine; NFV: Nelfinavir; DDI: Didanosine; ABV: Abacavir; EFV: Efavirenz; AZT: Zidovudina; IDV: Indinavir; RTV: Ritonavir.

^c In patient 4 VL value at baseline of 1200 correspond to a blip in viral load as, both prior and post values are < 20.